Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Brevitest Technologies is raising $5,049,000.00 in new funding. Sources indicate as part of senior management Co-Founder, Dev Chatterjee played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Brevitest Technologies
Everyone at Brevitest is focused on delivering you accurate, fast, easy, and informative clinical test results you can rely on to make important health care decisions. In 2013, we started as a humble sketch on a whiteboard, visualizing a way to make the complex reactions in a typical enzyme-linked immunosorbent assay (ELISA) so fast, easy, and reliable that almost anyone could run an immunoassay in less than 15 minutes. After over 8 years of development, we have finally turned that whiteboard sketch into a reality. Everyone wants clinical tests to be high quality so they can really know. Everyone wants information about their health to be available now. At Brevitest, we created a new technology that allows you to have both laboratory quality and point-of-care speed and convenience. We are a CLIA-certified clinical laboratory that leverages automation and cloud computing to deliver high-quality results in 15 minutes.

To learn more about Brevitest Technologies, visit http://www.brevitestlabs.com/

Contact:
Dev Chatterjee, Co-Founder
713-966-5844
https://www.linkedin.com/in/dev-chatterjee-2889725/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved